S100A4 and colorectal adenocarcinoma: In the present study, S100A4 over-expression was observed in 52 (53.06%) of the 98 colorectal adenocarcinoma tissue specimens, correlating closely with factors indicative of tumor aggressiveness, such as lymph node metastasis, depth of invasion, and peritoneal dissemination.